小细胞肺癌的新兴疗法与转化进展:克服耐药性
Emerging therapies and translational advances in small cell lung cancer: Overcoming resistance.
小细胞肺癌(SCLC)是一种侵袭性神经内分泌恶性肿瘤,以快速增殖、早期转移和预后不良为特征。
52.2分
★★★☆☆
ALL SOURCES
Emerging therapies and translational advances in small cell lung cancer: Overcoming resistance.
小细胞肺癌(SCLC)是一种侵袭性神经内分泌恶性肿瘤,以快速增殖、早期转移和预后不良为特征。
Pharmacotherapy for previously treated gastric cancer patients: current options and future developments.
生物标志物驱动的治疗有望在未来成为主流方法。
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。